Hans Lassmann

Neuropathology in multiple sclerosis: new concepts
Mult Scler 1998 4: 93-98. [Abstract] [PDF] [References]  

Hansotto Reiber

Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases
Mult Scler 1998 4: 99-107. [Abstract] [PDF] [References]  

P JH Jongen, S Floris, W H Doesburg, W AJG Lemmens, O R Hommes, and K JB Lamers

Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis
Mult Scler 1998 4: 108-110. [Abstract] [PDF] [References]  

H Reiber, S Ungefehr, and Chr Jacobi

The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
Mult Scler 1998 4: 111-117. [Abstract] [PDF] [References]  

I Cortese, S Capone, S Luchetti, L ME Grimaldi, A Nicosia, and R Cortese

CSF-enriched antibodies do not share specificities among MS patients
Mult Scler 1998 4: 118-123. [Abstract] [PDF] [References]  

K JB Lamers, H PM de Reus, and P JH Jongen

Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis
Mult Scler 1998 4: 124-126. [Abstract] [PDF] [References]  

Finn Sellebjerg, Michael Christiansen, and Peter Garred

MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis
Mult Scler 1998 4: 127-131. [Abstract] [PDF] [References]  

J L Frederiksen

Can CSF predict the course of optic neuritis?
Mult Scler 1998 4: 132-135. [Abstract] [PDF] [References]  

Hartmut Wekerle

Immune pathogenesis of multiple sclerosis. Brain autoimmune reactivity and its control by neuronal function
Mult Scler 1998 4: 136-137. [PDF] [References]  

G Giovannoni, A JE Green, and E J Thompson

Are there any body fluid markers of brain atrophy in multiple sclerosis?
Mult Scler 1998 4: 138-142. [Abstract] [PDF] [References]  

Philippe Monteyne and Christian JM Sindic

Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR
Mult Scler 1998 4: 143-146. [Abstract] [PDF] [References]  

J D Laman, C BM Maassen, M M Schellekens, L Visser, M Kap, E de Jong, M van Puijenbroek, M JB van Stipdonk, M van Meurs, C Schwärzler, and U Günthert

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide
Mult Scler 1998 4: 147-153. [Abstract] [PDF] [References]  

P Lozeron, D Chabas, B Duprey, O Lyon-Caen, and R Liblau

T cell receptor Vb5 and Vb17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients
Mult Scler 1998 4: 154-161. [Abstract] [PDF] [References]  

Anthony T Reder, Kursad Genc, Paul V Byskosh, and Anna Maria Porrini

Monocyte activation in multiple sclerosis
Mult Scler 1998 4: 162-168. [Abstract] [PDF] [References]  

M K Sharief

Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?
Mult Scler 1998 4: 169-173. [Abstract] [PDF] [References]  

A M Ferrarini, S Sivieri, M Buttarello, A Facchinetti, P Perini, and P Gallo

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-ß1b-treated multiple sclerosis patients
Mult Scler 1998 4: 174-177. [Abstract] [PDF] [References]  

Peter Rieckmann, Bernd Altenhofen, Antje Riegel, Boris Kallmann, and K Felgenhauer

Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis
Mult Scler 1998 4: 178-182. [Abstract] [PDF] [References]  

M Trojano, C Avolio, M Ruggieri, G Defazio, F Giuliani, D Paolicelli, and P Livrea

Serum soluble intercellular adhesion molecule-1 in MS: relation to clinical and Gd-MRI activity and to rIFNß-1b treatment
Mult Scler 1998 4: 183-187. [Abstract] [PDF] [References]  

Michel Chofflon and Benoît Fellay

Monitoring Multiple Sclerosis course and activity with TNF-alpha
Mult Scler 1998 4: 188-192. [PDF] [References]  

Jan Debruyne, Jan Philippé, Jacques Dereuck, Annick Willems, and Geert Leroux-Roels

Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?
Mult Scler 1998 4: 193-197. [Abstract] [PDF] [References]  

Myriam Schluep, Guy van Melle, Hugues Henry, Claudio Städler, Béatrice Roth-Wicky, and Pierre J Magistretti

In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis
Mult Scler 1998 4: 198-202. [Abstract] [PDF] [References]  

Piet Stinissen, Robert Medaer, and Jef Raus

Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis
Mult Scler 1998 4: 203-211. [Abstract] [PDF] [References]  

G Giovannoni, S J.R. Heales, J M Land, and E J Thompson

The potential role of nitric oxide in multiple sclerosis
Mult Scler 1998 4: 212-216. [Abstract] [PDF] [References]  

K Asakura and M Rodriguez

A unique population of circulating autoantibodies promotes central nervous system remyelination
Mult Scler 1998 4: 217-221. [Abstract] [PDF] [References]  

G Martino, R Furlan, F Galbiati, P L Poliani, A Bergami, L ME Grimaldi, L Adorini, and G Comi

A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines
Mult Scler 1998 4: 222-227. [Abstract] [PDF] [References]  

A R Massaro

Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?
Mult Scler 1998 4: 228-231. [Abstract] [PDF] [References]  

A J Coles, M G Wing, and D AS Compston

Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy
Mult Scler 1998 4: 232-238. [Abstract] [PDF] [References]  

S Luján, J Masjuan, E Roldán, L M Villar, P González-Porqué, and J C Álvarez-Cermeño

The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment
Mult Scler 1998 4: 239-242. [Abstract] [PDF] [References]  

John N Whitaker

Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes
Mult Scler 1998 4: 243-246. [Abstract] [PDF] [References]  

G Giovannoni and E J Thompson

Urinary markers of disease activity in multiple sclerosis
Mult Scler 1998 4: 247-253. [Abstract] [PDF] [References]  

P D Mehta, S D Cook, P K Coyle, R A Troiano, C S Constantinescu, and A M Rostami

Free light chains in multiple sclerosis urine
Mult Scler 1998 4: 254-256. [Abstract] [PDF] [References]  

Alan J Thompson

Identification of brain atrophy with MRI in MS
Mult Scler 1998 4: 257-259. [PDF] [References]  

G Comi, V Martinelli, T Locatelli, L Leocani, and S Medaglini

Neurophysiological and cognitive markers of disease evolution in multiple sclerosis
Mult Scler 1998 4: 260-265. [Abstract] [PDF] [References]  

J D Laman, E J Thompson, and L Kappos

Body fluid markers to monitor multiple sclerosis: the assays and the challenges
Mult Scler 1998 4: 266-269. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.